BRCA1 and cancer: To calculate PRSs we have used SNPs and corresponding log-OR estimates from external, population-based studies; therefore, the present analysis represents an independent validation of those externally derived PRSs and indicates that they are independently predictive of cancer risks for male carriers of BRCA1/2 mutations.